In particular anti-cancer drug Herceptin trastuzumab ()

Expressmation on the use and accuracy of the Breast Cancer TestsA new study finds that there is little information on the use of new testing technologies and targeted therapies in breast cancer, in particular anti-cancer drug Herceptin trastuzumab () . Published in the 15th November 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society recommends the review that many breast cancer patients trastuzumab trastuzumab can not benefit from it, and that some women who tested the drug has never been there for the receptor targets.

At the end the 12-week period, patients tai chi a significant decrease in knee pain compared with those in the control group. With the Western Ontario and McMaster Universities Osteoarthritis Index pain scale, the researchers put-118.80 reduction in pain from baseline between the Tai Chi and control groups. Researchers also observed improved physical function, self-efficacy, Depression, and health status for knee OA in subjects in the Tai Chi group. Our findings underscore the need to further evaluate the biologic mechanisms and approaches of Tai Chi to extend the benefits to a broader population, concluded Dr.

medication information

Information is on by courtesy from the Henry J. Kaiser Family Foundation , you can enjoy the full the Emperor. Daily Health policy coverage search in the archives and log on email delivery at kaiser HealthNews.